Arvilap Active substance: Rabbit haemorrhagic disease virus, strain VHD-1, Inactivated Route of administration: Subcutaneous use Pharmaceutical form: Suspension for injection Target species: Rabbit Authorised in: Netherlands Product status: Authorised Compare